Drug Shortage Report for BRIMONIDINE P

Last updated on 2018-07-17 History
Report ID 43918
Drug Identification Number 02301334
Brand name BRIMONIDINE P
Common or Proper name BRIMONIDINE P
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.15%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 5ml
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-03-26
Estimated end date 2018-07-18
Actual end date 2018-07-16
Shortage status Resolved
Updated date 2018-07-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2018-07-17 English Compare
v13 2018-07-16 French Compare
v12 2018-07-16 English Compare
v11 2018-06-25 French Compare
v10 2018-06-25 English Compare
v9 2018-05-30 French Compare
v8 2018-05-30 English Compare
v7 2018-05-24 French Compare
v6 2018-05-24 English Compare
v5 2018-04-23 French Compare
v4 2018-04-23 English Compare
v3 2018-03-27 English Compare
v2 2018-03-26 French Compare
v1 2018-03-26 English Compare

Showing 1 to 14 of 14